ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published online before print February 5, 2009, 10.1183/09031936.00084307
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplementary figure
Right arrow All Versions of this Article:
33/6/1415    most recent
09031936.00084307v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Permissions
Right arrowRequest Permissions
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Mato, N.
Right arrow Articles by Sugiyama, Y.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mato, N.
Right arrow Articles by Sugiyama, Y.
Eur Respir J 2009; 33:1415-1428
Copyright ©ERS Journals Ltd 2009

Interleukin-1 receptor-related protein ST2 suppresses the initial stage of bleomycin-induced lung injury

N. Mato1, M. Fujii2, Y. Hakamata3, E. Kobayashi4, A. Sato5, M. Hayakawa2, H. Ohto-Ozaki2, M. Bando1, S. Ohno1, S. Tominaga2 and Y. Sugiyama1

1 Division of Pulmonary Medicine, Dept of Medicine, Jichi Medical University, 2 Dept of Biochemistry, Jichi Medical University, 4 Division of Organ Replacement Research, Center for Molecular Medicine, Jichi Medical University, and, 5 Dept of Dermatology, Jichi Medical University, Tochigi, and 3 Dept of Basic Science, School of Veterinary Nursing and Technology, Nippon Veterinary and Life Science University, Musashino-shi, Japan.

CORRESPONDENCE: Y. Sugiyama, Division of Pulmonary Medicine, Jichi Medical University, 3311-1 Yakushiji, Shimotsuke-Shi, Tochigi 329-0498, Japan. Fax: 81 285443586. E-mail: sugiyuki{at}jichi.ac.jp

Keywords: Acute lung injury, bleomycin, hydrodynamic injection, ST2

Received: July 7, 2007
Accepted January 13, 2009

Acute lung injury has a range of causes, and occasionally leads to lethal respiratory failure. Despite advances in treatment, acute lung injury continues to have a high mortality rate, and thus a new therapeutic approach is needed. ST2 is an interleukin (IL)-1 receptor-related protein, and its expression is induced by various inflammatory responses. Recently, ST2 has been speculated to exert anti-inflammatory effects; therefore, we investigated the role of the ST2 in the murine model of acute lung injury.

To elucidate the function of ST2 in vivo, mice that transiently overexpressed ST2 protein were prepared using the hydrodynamic gene transfer method, and lung injury was induced by intratracheal administration of bleomycin.

In bleomycin-treated ST2-overexpressing mice, the increase of neutrophils in the bronchoalveolar lavage fluid (BALF) was markedly suppressed. Additionally, the levels of tumour necrosis factor-{alpha} and IL-6, as well as the concentration of albumin, in BALF were reduced compared with those of controls. Furthermore, the pulmonary architecture in ST2-overexpressing mice remained almost normal, and the survival rate was significantly improved.

From these results, we concluded that ST2 has the potential to suppress the initial stage of acute lung injury, and therefore it may be a useful reagent for the treatment of acute lung injury.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2009 by the European Respiratory Society.